A Prospective Controlled Phase II Study of Preoperative Exisulind Therapy Initiated Prior to Radical Prostatectomy: Effect on Apoptosis
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
4 week changes in apoptosis biomarkers
Bradley C. Leibovich, M.D.
United States: Food and Drug Administration
|Mayo Clinic||Rochester, Minnesota 55905|